Pharmaceuticals: Ventipulmin®

Active Ingredient

Clenbuterol

Indication

• Treatment of acute and chronic respiratory disease where airway obstruction due to bronchospasm and/or mucus accumulation is a contributing factor and improved mucociliary clearance is desirable
• To be used alone or as adjunctive therapy in Chronic Obstructive Pulmonary Disease (COPD)
• Acute, sub-acute and chronic respiratory allergic conditions

Characteristics

Ventipulmin® provides effective and sustained control of allergic non-infectious respiratory disorders.

Ventipulmin® is also an adjunctive therapy in combination with antibiotics for the treatment of infectious respiratory disorders as it leads to peak performance in respiratory function and working.

Application

powder for oral administration